Contraception Can Prevent Maternal Morbidity and Mortality from Congenital Heart Disease

Highly effective reversible contraceptives are underutilized by women with CHD.

With improved survival, more women with congenital heart disease (CHD) are at risk for pregnancy. Investigators used a nationwide U.S. database from 2000 through 2010 to identify delivery hospitalizations in women with and without CHD (10,700 and 12,500,000, respectively). During the study period, CHD prevalence increased from 6.4 to 9.0 per 1000 deliveries. The most common types of congenital heart lesions included septal defects and valvular lesions. Disorders of pulmonary circulation were present in 3% of women with CHD. Incidence of maternal death, need for mechanical ventilation, and a composite cardiovascular outcome (including events such as myocardial infarction, cardiac arrest, and stroke) were higher among women with CHD. A variet…

Reviewing Author

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health

Andrew M. Kaunitz, MD

Disclosures

RoyaltiesUpToDate

Grant/Research SupportMerck, Mithra, Medicines360

Editorial BoardsContraception; Menopause; Contraceptive Technology Update; OBG Management; Medscape OB/GYN & Women’s Health

Contraception Can Prevent Maternal Morbidity and Mortality from Congenital Heart Disease

Topics

Reviewing Author